Development of a light-activated STING agonist
Literature Information
Steven E. Caldwell, Chasity P. Janosko
The STING pathway is critical to innate immunity and is being investigated as a potential therapeutic target. Existing agents targeting STING suffer from several undesirable effects, particularly the possibility of systematic activation, which increases the risk of autoimmune disorders. In this proof-of-concept study, we report the development of a light-activated STING agonist, based on the potent compound SR-717. We first screened the activity of the non-caged agonist toward 5 human STING variants to identify the most viable target. A photocaged agonist was designed and synthesized in order to block an essential interaction between the carboxy acid group of the ligand with the R238 residue of the STING protein. We then investigated the selective activation of STING with the photocaged agonist, demonstrating an irradiation-dependent response. The development and characterization of this selective agonist expands the growing toolbox of conditionally controlled STING agonists to avoid systematic immune activation.
Related Literature
Demonstration of green hydrogen production using solar energy at 28% efficiency and evaluation of its economic viability
M. A. Khan, I. Al-Shankiti, A. Ziani, H. Idriss
DOI: 10.1039/D0SE01761B
Ferrocene-based porous organic polymer derived N-doped porous carbon/Fe3C nanocrystal hybrids towards high-efficiency ORR for Zn–air batteries
Xia Liu, Xiaoming Liang, Han Lou, Huiru Wang, Hui Li, Shujuan Zhang, Shourong Zhu, Weina Han
DOI: 10.1039/D0SE01692F
Insights into the phenomenon of ‘bubble-free’ electrocatalytic oxygen evolution from water
Richard Terrett, Zheyin Yu, Zhenxiang Cheng, Gerhard F. Swiegers, Takuya Tsuzuki, Robert Stranger, Ronald J. Pace
DOI: 10.1039/D0SE01633K
Phase-controllable polymerized ionic liquids for CO2 fixation into cyclic carbonates
Chaokun Yang, Yanglin Chen, Ye Qu, Jiaxu Zhang, Jianmin Sun
DOI: 10.1039/D0SE01293A
Enhanced photoelectrochemical performance from particulate ZnSe:Cu(In,Ga)Se2 photocathodes during solar hydrogen production via particle size control
Fumiaki Takagi
DOI: 10.1039/D0SE00998A
A hierarchical CoP@NiCo-LDH nanoarray as an efficient and flexible catalyst electrode for the alkaline oxygen evolution reaction
Wenli Tian, Jie Zhang, Hao Feng, Hao Wen, Xun Sun, Xin Guan, Dengchao Zheng, Jing Liao, Minglei Yan, Yadong Yao
DOI: 10.1039/D0SE01490G
Tungsten oxide-coated copper gallium selenide sustains long-term solar hydrogen evolution
David W. Palm, Christopher P. Muzzillo, Micha Ben-Naim, Imran Khan, Nicolas Gaillard
DOI: 10.1039/D0SE00487A
Improving the electrocatalytic performance of sustainable Co/carbon materials for the oxygen evolution reaction by ultrasound and microwave assisted synthesis
Alessio Zuliani, Manuel Cano, Federica Calsolaro, Alain R. Puente Santiago, Juan J. Giner-Casares, Enrique Rodríguez-Castellón, Gloria Berlier, Giancarlo Cravotto, Katia Martina
DOI: 10.1039/D0SE01505A
Analysis of manufacturing cost and market niches for Cu2ZnSnS4 (CZTS) solar cells
Ao Wang, Nathan L. Chang, Kaiwen Sun, Chaowei Xue, Renate J. Egan, Jianjun Li, Chang Yan, Jialiang Huang, Hui Rong, Charles Ramsden, Xiaojing Hao
DOI: 10.1039/D0SE01734E
You might also like
What regulatory guidelines apply to 4-Amino-3-bromophenol (CAS: 74440-80-5)?
4-Amino-3-bromophenol (CAS: 74440-80-5) falls under the classification of a haza...
How should (17beta)-3-Oxoestr-4-en-17-yl acetate (CAS: 1425-10-1) be stored?
(17beta)-3-Oxoestr-4-en-17-yl acetate should be stored in a cool, dry place away...
What are the physical and chemical properties of 2-[(2,2-Diethoxyethyl)disulfanyl]-1,1-diethoxyethane (CAS: 76505-71-0)?
2-[(2,2-Diethoxyethyl)disulfanyl]-1,1-diethoxyethane (CAS: 76505-71-0) is a colo...
What is the market or research trend for 1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridin-4-amine?
The market and research for 1-(β-D-ribofuranosyl)-1H-imidazo[4,5-c]pyridin-4-ami...
How should waste containing Conjugated Estrogen (CAS: 12126-59-9) be handled?
Waste containing Conjugated Estrogen (CAS: 12126-59-9) should be collected and d...
What is the market or research trend for Bis(2,2,2-trifluoroethyl) (methoxycarbonylmethyl)phosphonate?
The market for Bis(2,2,2-trifluoroethyl) (methoxycarbonylmethyl)phosphonate (CAS...
Are there alternatives to 3,4'-Di-O-methylellagic acid (CAS: 57499-59-9) in synthesis?
There are several alternatives to 3,4'-Di-O-methylellagic acid (CAS: 57499-59-9)...
What regulatory guidelines apply to 2-Chloro-N,N-dimethylpyridin-4-amine (CAS: 59047-70-0)?
2-Chloro-N,N-dimethylpyridin-4-amine (CAS: 59047-70-0) is regulated under the Gl...
What is cerium(3+);oxygen(2-);vanadium(5+) (CAS: 13597-19-8)?
Cerium(3+);oxygen(2-);vanadium(5+) (CAS: 13597-19-8) is a complex inorganic comp...
Is 7-Chloro-1-iodoisoquinoline (CAS: 1203579-27-4) safe?
7-Chloro-1-iodoisoquinoline (CAS: 1203579-27-4) is generally considered safe whe...
Source Journal
Organic & Biomolecular Chemistry

Organic & Biomolecular Chemistry (OBC) publishes original and high impact research and reviews in organic chemistry. We welcome research that shows new or significantly improved protocols or methodologies in total synthesis, synthetic methodology or physical and theoretical organic chemistry as well as research that shows a significant advance in the organic chemistry or molecular design aspects of chemical biology, catalysis, supramolecular and macromolecular chemistry, theoretical chemistry, mechanism-oriented physical organic chemistry, medicinal chemistry or natural products. Articles published in the journal should report new work which makes a highly-significant impact in the field. Routine and incremental work is generally not suitable for publication in the journal. More details about key areas of our scope are below. In all cases authors should include in their article clear rationale for why their research has been carried out.













![4-[(2-Fluoro-4-methylphenyl)amino]-6-[4-(2-hydroxyethyl)-1-piperazinyl]-7-methoxy-3-cinnolinecarboxamide structure 4-[(2-Fluoro-4-methylphenyl)amino]-6-[4-(2-hydroxyethyl)-1-piperazinyl]-7-methoxy-3-cinnolinecarboxamide structure](https://static.chemtradehub.com/structs/104/1041852-85-0-fb1c.webp)
![2-Methyl-2-propanyl 4-[3-(aminomethyl)phenyl]-1-piperazinecarboxylate structure 2-Methyl-2-propanyl 4-[3-(aminomethyl)phenyl]-1-piperazinecarboxylate structure](https://static.chemtradehub.com/structs/889/889948-55-4-5c12.webp)